Alexia Karen Cotte

Alexia Karen Cotte

Auto-generated profile, based on publicly available information

Alexia Karen Cotte

UFR Sciences de Santé, Université de Bourgogne, 21000 Dijon, France

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
ACAlexia Karen Cotte
Alexia Karen Cotte
VAVirginie Aires
Virginie Aires
MFMaxime Fredon
Maxime Fredon
ELEmeric Limagne
Emeric Limagne
VDValentin Derangère
Valentin Derangère
Dominique DelmasDominique Delmas
Dominique Delmas
Lipid droplet (LD) accumulation is a now well-recognised hallmark of cancer. However, the significance of LD accumulation in colorectal cancer (CRC) biology is incompletely understood under chemotherapeutic conditions. Since drug resistance is a major obstacle to treatment success, we sought to determine the contribution of LD accumulation to chemotherapy resistance in CRC. Here we show that LD content of CRC cells positively correlates with the expression of lysophosphatidylcholine acyltransferase 2 (LPCAT2), an LD-localised enzyme supporting phosphatidylcholine synthesis. We also demonstrate that LD accumulation drives cell-death resistance to 5-fluorouracil and oxaliplatin treatments both in vitro and in vivo. Mechanistically, LD accumulation impairs caspase cascade activation and ER stress responses. Notably, droplet accumulation is associated with a reduction in immunogenic cell death and CD8+ T cell infiltration in mouse tumour grafts and metastatic tumours of CRC patients. Collectively our findings highlight LPCAT2-mediated LD accumulation as a druggable mechanism to restore CRC cell sensitivity.

14 March 2013 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
VAVirginie Aires
Virginie Aires
ELEmeric Limagne
Emeric Limagne
ACAlexia K. Cotte
Alexia K. Cotte
NLNorbert Latruffe
Norbert Latruffe
Ghiringhelli FrançoisGhiringhelli François
Ghiringhelli François
Dominique DelmasDominique Delmas
Dominique Delmas

15 March 2019 in Oncotarget
Verified
Journal Article
Open access
PDF file
ACAlexia Karen Cotte
Alexia Karen Cotte
VCVanessa Cottet
Vanessa Cottet
VAVirginie Aires
Virginie Aires
TMThomas Mouillot
Thomas Mouillot
MRMaud Rizk
Maud Rizk
Dominique DelmasDominique Delmas
Dominique Delmas
Phospholipid profiles and hepatocellular carcinoma risk and prognosis in cirrhotic patients Phospholipid profiles and hepatocellular carcinoma risk and prognosis in cirrhotic patients

15 July 2013 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Dominique DelmasDominique Delmas
Dominique Delmas
VAVirginie Aires
Virginie Aires
DCDidier J. Colin
Didier J. Colin
ELEmeric Limagne
Emeric Limagne
ASAlessandra Scagliarini
Alessandra Scagliarini
Ghiringhelli FrançoisGhiringhelli François
Ghiringhelli François

22 September 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
FCFlavie Courtaut
Flavie Courtaut
VDValentin Derangère
Valentin Derangère
ACAngélique Chevriaux
Angélique Chevriaux
SLSylvain Ladoire
Sylvain Ladoire
ACAlexia K. Cotte
Alexia K. Cotte
CRCédric REBE
Cédric REBE
Liver X Receptor ligand cytotoxicity in colon cancer cells and not in normal colon epithelial cells depends on LXRβ subcellular localization

11 April 2018 in Molecular & Cellular Oncology
Verified
Journal Article
Open access
ACAlexia Karen Cotte
Alexia Karen Cotte
VAVirginie Aires
Virginie Aires
FGFrançois Ghiringhelli
François Ghiringhelli
DDDominique Delmas
Dominique Delmas
Lipid droplets (LD) are now-well recognized as playing a role in cancer progression, however their potential role in chemoresistance remains largely unknown, particularly in colorectal cancer (CRC). We recently highlighted that LD accumulate in CRC cells under the control of lysophosphatidylcholine acyltransferase 2 (LPCAT2) enzyme expression. We also showed that chemotherapy-induced LD accumulation counteracts intrinsic and extrinsic cancer cell death activation.